Currently holds a position at Plus Therapeutics Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Director | Plus Therapeutics Inc | Sept. 2, 2014 - |
President, Chief Executive Officer, Principal Financial Officer, Director | Plus Therapeutics Inc | Aug. 11, 2014 - Sept. 2, 2014 |
President, Chief Executive Officer, Director | Plus Therapeutics Inc | April 2, 2014 - Aug. 11, 2014 |
President, Director | Plus Therapeutics Inc | May 1, 2004 - April 2, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-12-15 | 2023-11-20 |
Plus Therapeutics Inc
(PSTV)
|
S Sale |
2,068
-92.4%
1.964,053 USD |
2,068 -92.4% | 1.96 | 4,053 USD | |
2022-04-28 | 2022-04-26 |
Plus Therapeutics Inc
(PSTV)
|
B Purchase |
2,500
+9.6%
0.681,710 USD |
2,500 +9.6% | 0.68 | 1,710 USD | |
2022-04-27 | 2022-04-26 |
Plus Therapeutics Inc
(PSTV)
|
B Purchase |
5,000
+23.7%
0.693,450 USD |
5,000 +23.7% | 0.69 | 3,450 USD | |
2021-10-27 | 2021-10-26 |
Plus Therapeutics Inc
(PSTV)
|
B Purchase |
2,500
+13.5%
1.664,150 USD |
2,500 +13.5% | 1.66 | 4,150 USD | |
2021-05-03 | 2021-04-30 |
Plus Therapeutics Inc
(PSTV)
|
B Purchase |
2,183
+13.3%
2.284,970 USD |
2,183 +13.3% | 2.28 | 4,970 USD | |
2021-03-05 | 2021-03-04 |
Plus Therapeutics Inc
(PSTV)
|
B Purchase |
2,500
+18.0%
2.506,250 USD |
2,500 +18.0% | 2.50 | 6,250 USD | |
2020-12-14 | 2020-12-10 |
Plus Therapeutics Inc
(PSTV)
|
B Purchase |
2,500
+22.0%
1.994,975 USD |
2,500 +22.0% | 1.99 | 4,975 USD | |
2020-12-02 | 2020-11-30 |
Plus Therapeutics Inc
(PSTV)
|
B Purchase |
2,200
+24.0%
2.144,708 USD |
2,200 +24.0% | 2.14 | 4,708 USD | |
2020-08-13 | 2020-08-12 |
Plus Therapeutics Inc
(PSTV)
|
B Purchase |
4,000
+77.4%
2.5810,318 USD |
4,000 +77.4% | 2.58 | 10,318 USD | |
2020-06-23 | 2020-06-22 |
Plus Therapeutics Inc
(PSTV)
|
B Purchase |
5,000
+2994.0%
2.1010,500 USD |
5,000 +2994.0% | 2.10 | 10,500 USD |